Bilol comp. 5/12.5
Bilol comp. 5/12.5 is a medicine authorised by Swissmedic under authorisation number 57382. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 November 2005 and the authorisation is valid without a time limit. ATC code C07BB07 places the medicine in the group Beta blocking agents.
| Authorisation number | 57382 |
|---|---|
| Name | Bilol comp. 5/12.5 |
| Full name | Bilol comp. 5/12.5, Filmtabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C07BB07 |
| First authorisation | 29 November 2005 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Bilol comp. 5/12.5, Filmtabletten | B | 29 November 2005 |
| 2 | Bilol comp. 10/25, Filmtabletten | B | 29 November 2005 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | C07BB07 | 02.07.2. | B |
| 3 | 100 | Tablette(n) | C07BB07 | 02.07.2. | B |
| 5 | 30 | Tablette(n) | C07BB07 | 02.07.2. | B |
| 7 | 100 | Tablette(n) | C07BB07 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Bilol comp. 5/12.5 authorised in Switzerland?
Yes. Bilol comp. 5/12.5 is authorised by Swissmedic under authorisation number 57382, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Bilol comp. 5/12.5 have?
Bilol comp. 5/12.5 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Bilol comp. 5/12.5?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.